Literature DB >> 3084124

Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.

J E Gage, O M Hess, T Murakami, M Ritter, J Grimm, H P Krayenbuehl.   

Abstract

To study the vasomotility of normal and diseased coronary arteries during dynamic exercise, symptom-limited supine bicycle exercise during cardiac catheterization was performed by 18 patients with classic angina pectoris. The cardiovascular response was assessed by hemodynamic measurements and computer-assisted determination of normal and stenotic coronary artery luminal areas from biplane coronary angiograms made before, during, and after exercise. After baseline measurements were recorded, 12 patients (group 1) performed bicycle exercise for 3.4 min (mean), reaching a maximum workload of 81 W (mean); at the end of exercise they received 1.6 mg sublingual nitroglycerin. After measurements at rest in six other patients (group 2), 0.1 mg intracoronary nitroglycerin was given, followed by exercise (3.8 min, 96 W; NS) and sublingual nitroglycerin as in group 1. During exercise in group 1, luminal area of the coronary stenosis decreased to 71% of resting levels (p less than .001), while area of the normal coronary artery increased to 123% of control (p less than .001). After sublingual nitroglycerin at the end of exercise, area of the normal vessel further increased to 140% of control (p less than .001), while luminal area of the stenosis dilated to 112% of resting levels (p less than .001 vs exercise, NS vs rest). Pretreatment with intracoronary nitroglycerin increased both normal (121%; p less than .05) and stenotic (122%; p less than .05) luminal areas, while preventing the previously observed narrowing of stenosis during exercise (114%; NS). Exercise resulted in a similar heart rate-systolic pressure product and caused angina pectoris in two-thirds of the patients in each group. However, patients pretreated with intracoronary nitroglycerin (group 2) had a lower mean pulmonary arterial pressure during maximum exercise (35 mm Hg) than those patients (group 1) not receiving pretreatment (47 mm Hg; p less than .001). Group 2 patients reached a percentage of their predicted work capacity (65%) that was about the same as that during previous upright bicycle exercise (71%; NS), while group 1 patients had a significantly lower work capacity (51% of predicted) than that before catheterization (82%; p less than .001). Hence, narrowing of coronary artery stenosis during dynamic exercise is attributable to active vasoconstriction due to its reversibility by preexercise intracoronary nitroglycerin. Patients who did not experience narrowing of stenosis during exercise (group 2) had less evidence of myocardial ischemia (lower mean pulmonary arterial pressure) and maintained their work capacity.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084124     DOI: 10.1161/01.cir.73.5.865

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.

Authors:  D Tousoulis; G J Davies; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

2.  Validation of a new automatic system for biplane quantitative coronary arteriography.

Authors:  M Büchi; O M Hess; R L Kirkeeide; T Suter; M Muser; H P Osenberg; P Niederer; M Anliker; K L Gould; H P Krayenbühl
Journal:  Int J Card Imaging       Date:  1990

3.  Pharmacology of the coronary circulation.

Authors:  J C Sill
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

Review 4.  Increased coronary tone in exertional angina: the beneficial effects of calcium antagonists.

Authors:  G Specchia; D Ardissino; S Ghio; P Barberis; M L Colombo; S De Servi
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

5.  Elimination of variable vasomotor tone in studies with repeated quantitative coronary angiography.

Authors:  S Jost; W Rafflenbeul; G H Reil; H J Trappe; D Gulba; H Hecker; U Gerhardt; I Knop
Journal:  Int J Card Imaging       Date:  1990

6.  Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction.

Authors:  D Elizabeth Le; Eric R Powers; Jian-Ping Bin; Howard Leong-Poi; N Craig Goodman; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

7.  Attenuation of contraction of isolated canine coronary arteries by enflurane and halothane.

Authors:  G A Blaise; J M Hughes; J C Sill; J N Buluran; G Caille
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

Review 8.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

Review 9.  Management of vasospastic angina--role of nicorandil.

Authors:  J C Kaski
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 10.  Nitrate tolerance. A review of the evidence.

Authors:  J T Flaherty
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.